Treatment of fibrodysplasia ossificans progressiva
PH12022551702B1Active Publication Date: 2026-08-19REGENERON PHARMACEUTICALS INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12022551702
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2022-07-08
- Publication Date
- 2026-08-19
- Estimated Expiration
- 2042-07-08
Abstract
Methods for treating fibrodysplasia ossificans progressiva (FOP) in human subjects are provided. Such methods involve administering to a subject having FOP a therapeutically effective amount of an Activin A antagonist, such as an antibody against Activin A
Need to check novelty before this filing date? Find Prior Art